Sutro Share Price

Sutro Share Price

NASDAQ: STRO | Micro Cap | Healthcare
$8.60
-$0.10 (-1.09%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Sutro Stock Performance

Open
$8.78
Prev. Close
$8.70
Circuit Range
N/A
Day Range
$8.46 - $8.99
Year Range
$0.72 - $42.38
Volume
8,622
Average Traded
$8.66

Sutro Share Price Today

As of 22 November 2026, Sutro Biopharma, Inc.'s share price is $8.60. The stock opened at $8.78, compared to its previous close of $8.70. During today's trading session, Sutro Biopharma, Inc.'s share price traded between $8.46 and $8.99, with an average price of $8.73. Over the past 52 weeks, the stock has recorded a high of $42.38 and a low of $0.72. In terms of performance, Sutro Biopharma, Inc.'s share price has declined by 70.30% over the last six months and is up 839.89% on a year-on-year basis.

Sutro Share Price Chart

Line chart of the Sutro price trend over the selected period. The price fell overall, ranging from 8.46 to 8.99, ending at 8.60.
$8.46$8.99
L
Show Current Price
H

Sutro Stock Fundamentals & Key Indicators

Market Cap
$73.08M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.35
Revenue (TTM)
$102.48B
Return On Equity (TTM)
117.15%
Profit Margin
-186.47%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.66%

Sutro Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$11.65$14.52$9.84$9.10
Net Profit-$46.76-$38.48-$38.53-$31.49
Net Profit Margin-401.37%-265.01%-391.57%-346.04%
Income ChangeN/A17.71%-0.13%18.27%

Sutro Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$67.77$153.73$62.04$102.48
Net Profit-$119.20-$106.79-$227.46-$191.09
Net Profit Margin-175.89%-69.47%-366.63%-186.47%
Income ChangeN/A10.41%-113.00%15.99%

Sutro Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets22.943.949.1953.79
Current Assets150.93343.31421.54353.15
Total Assets173.83387.21470.74406.94
Non Current Liabilities231.15210.71227.34123.35
Current Liabilities75.13131.8993.7566.55
Total Liabilities306.28342.61321.09189.9
Shareholders' Equity-132.4544.6149.65217.05

Sutro Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-177.23-191.54-111.623.55
Investing45.01218.51-3.92-35.02
Financing0.0494.05137.5548.31

Corporate Actions

Split
Ex-date: 03 Dec 2025

About Sutro

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Sutro Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.97
$8.61
-5.18%
Oct 2026
$15.99
$9.08
-44.16%
Sep 2026
$20.29
$16.26
-24.16%
Aug 2026
$23.35
$21.44
-11.29%
Jul 2026
$32.76
$24.17
-27.30%
Jun 2026
$28.31
$33.24
+14.82%
May 2026
$37.12
$28.95
-21.18%
Apr 2026
$25.53
$36.73
+48.01%
Mar 2026
$19.69
$24.82
+20.25%
Feb 2026
$14.76
$20.64
+40.41%
Jan 2026
$11.44
$14.70
+28.22%
Dec 2025
$0.85
$11.46
+1,153.01%

Sutro Share Price FAQs